Clinical Trial Update: Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10) [Phase 2]

View source ↗

Summary

Phase 2 trial update for Oleogel-S10 in wound healing of inherited Epidermolysis Bullosa (BE B-10) has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inherited Epidermolysis Bullosa

Drugs mentioned

• Oleogel-S10

Snippet

Sponsor: Birken AG | Conditions: Inherited Epidermolysis Bullosa | Phase 2 | Status: COMPLETED | Results posted: 2018-01-23